| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K75293299 | CTRPv2 | pan-cancer | AAC | 0.012 | 0.9 |
| mRNA | narciclasine | CTRPv2 | pan-cancer | AAC | -0.0047 | 0.9 |
| mRNA | Roscovitine | GDSC1000 | pan-cancer | AAC | 0.008 | 0.9 |
| mRNA | BRD-K71781559 | CTRPv2 | pan-cancer | AAC | -0.0055 | 0.9 |
| mRNA | EHT 1864 | GDSC1000 | pan-cancer | AAC | 0.0049 | 0.9 |
| mRNA | AEW541 | CCLE | pan-cancer | AAC | 0.0064 | 0.9 |
| mRNA | YM-155 | CTRPv2 | pan-cancer | AAC | 0.0052 | 0.9 |
| mRNA | GDC-0941 | gCSI | pan-cancer | AAC | 0.0081 | 0.9 |
| mRNA | BMS-509744 | GDSC1000 | pan-cancer | AAC | -0.0073 | 0.9 |
| mRNA | BRD-A02303741:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.0047 | 0.9 |